Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
CARLSBAD, Calif., Sept. 11, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today its participation at the 2024 Cantor Global Healthcare Conference.
加利福尼亞州卡爾斯巴德,2024年9月11日 /PRNewswire/ — TYRA Biosciences, Inc.(納斯達克股票代碼:TYRA)是一家臨床階段的生物技術公司,專注於開發針對成纖維細胞生長因子受體(FGFR)生物學巨大機遇的下一代精準藥物,今天宣佈參加2024年坎託全球醫療大會。
Todd Harris, CEO of TYRA, will participate in a fireside chat on Tuesday, September 17, 2024, at 9:45 am ET. TYRA management will also participate in one-on-one meetings with investors during the conference.
TYRA首席執行官託德·賀錦麗將於美國東部時間2024年9月17日星期二上午9點45分參加爐邊談話。在會議期間,TYRA管理層還將參加與投資者的一對一會議。
A live and archived webcast of the fireside chat will be available via the For Investors page on the Investor section of the TYRA website.
爐邊談話的直播和存檔網絡直播將通過TYRA網站 「投資者」 部分的 「投資者專區」 頁面提供。
About Tyra Biosciences
關於泰拉生物科學
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.
Tyra Biosciences, Inc.(納斯達克股票代碼:TYRA)是一家臨床階段的生物技術公司,專注於開發針對FGFR生物學巨大機遇的下一代精準藥物。該公司的內部精準醫療平台SNAP可通過迭代的分子Snapshots實現快速而精確的藥物設計,這有助於預測最有可能導致現有療法獲得性耐藥性的基因變化。TYRA最初的重點是應用其加速小分子藥物發現引擎來開發靶向腫瘤學和基因定義條件下的療法。TYRA 總部位於加利福尼亞州卡爾斯巴德。
For more information about our science, pipeline and people, please visit and engage with us on LinkedIn.
如需了解有關我們的科學、管道和人員的更多信息,請訪問LinkedIn並與我們互動。
Contact:
聯繫人:
Amy Conrad
[email protected]
艾米康拉德
[電子郵件保護]
SOURCE Tyra Biosciences
來源 Tyra 生物科學
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想在 PRNEWSWIRE.COM 上刊登貴公司的新聞嗎?
譯文內容由第三人軟體翻譯。